{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:59:59Z","timestamp":1771603199529,"version":"3.50.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Despite the clinical guidelines favoring medical therapy for stable angina, the optimal management of these patients remains unclear. Here, we compare medical management (MM) versus percutaneous coronary intervention (PCI) in patients with stable angina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An extensive literature search was conducted using PubMed and Embase to identify randomized controlled trials of interest. Data were extracted and analyzed using a random-effects model to calculate pooled odds ratios (OR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Our meta-analysis of 28 randomized controlled trials included 9346 PCI patients and 9503 medically managed patients. The mean age was 62.5\u2009\u00b1\u20097.6 years in the PCI group and 62.8\u2009\u00b1\u20097.4 years in the other group. Men comprised 68% and 70% of the PCI and MM groups, respectively.<\/jats:p>\n                    <jats:p>\n                      Over a mean follow-up of 2.64 years, PCI was associated with a significantly lower incidence of myocardial infarction compared with MM (OR, 0.84; 95% CI, 0.74\u20130.96;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01). Although PCI showed trends toward lower odds of unplanned revascularizations and major adverse cardiovascular (CV) events, these differences were not statistically significant. There were no differences in outcomes of freedom from angina, unstable angina, nonfatal myocardial infarction, stroke, all-cause mortality, or CV death.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Advances in CV imaging and catheterization techniques have improved risk stratification and outcomes of PCI in stable angina. Further research is needed to identify clinical subgroups that benefit most from each treatment modality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/hpc.0000000000000406","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T04:00:08Z","timestamp":1761278408000},"page":"e0406","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Medical Management Versus PCI in Patients with Stable Angina: An Updated Systematic Review and Meta-analysis"],"prefix":"10.1097","volume":"25","author":[{"given":"Prakash","family":"Upreti","sequence":"first","affiliation":[{"name":"Sands-Constellation Heart Institute, Rochester Regional Health, Rochester, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Hanmandlu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University\/Detroit Medical Center, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Rasheed","family":"Bahar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wayne State University\/Detroit Medical Center, Detroit, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Hamza","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Guthrie Medical Group, Cortland, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Turkmani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Michigan State University, East Lansing, MI"},{"name":"Department of Internal Medicine, McLaren Health Care, Oakland, MI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Rathore","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Macon & Joan Brock Virginia Health Sciences, Old Dominion University, Norfolk, VA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad","family":"Basit","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kripa","family":"Rajak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Missouri, Columbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Yasmin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University Hospital, New Haven, CT"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman Abdul","family":"Basit","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, The Wright Center for GME, Scranton, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Chadi","family":"Alraies","sequence":"additional","affiliation":[{"name":"Wayne State University\/Detroit Medical Center, Cardiovascular Institute, Detroit, MI."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"R1-20260220","article-title":"Global epidemiology of ischemic heart disease: results from the global burden of disease study.","author":"Khan","year":"2020","journal-title":"Cureus"},{"key":"R2-20260220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028193","article-title":"Global, regional, and national burdens of ischemic heart disease attributable to smoking from 1990 to 2019.","volume":"12","author":"Zhang","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"R3-20260220","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heartjnl-2017-311446","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need.","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"key":"R4-20260220","doi-asserted-by":"crossref","first-page":"e004080","DOI":"10.1161\/JAHA.116.004080","article-title":"Angina and future cardiovascular events in stable patients with coronary artery disease: insights from the Reduction of Atherothrombosis for Continued Health (REACH) registry.","volume":"5","author":"Eisen","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R5-20260220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1074248416679733","article-title":"Angina and its management.","volume":"22","author":"Kloner","year":"2017","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R6-20260220","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2021.1527","article-title":"Diagnosis and management of stable angina: a review.","volume":"325","author":"Joshi","year":"2021","journal-title":"JAMA"},{"key":"R7-20260220","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"key":"R8-20260220","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/MCA.0000000000000516","article-title":"Novel molecular targets for coronary angiogenesis and ischemic heart disease.","volume":"28","author":"Potz","year":"2017","journal-title":"Coron Artery Dis"},{"key":"R9-20260220","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.295.21.2511","article-title":"Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.","volume":"295","author":"Hochman","year":"2006","journal-title":"JAMA"},{"key":"R10-20260220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1205361","article-title":"Fractional flow reserve\u2013guided PCI versus medical therapy in stable coronary disease.","volume":"367","author":"De Bruyne","year":"2012","journal-title":"N Engl J Med"},{"key":"R11-20260220","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease.","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"R12-20260220","first-page":"1","article-title":"Medical therapy versus percutaneous coronary intervention or coronary artery bypass graft in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.","volume":"18","author":"Davari","year":"2022","journal-title":"ARYA Atheroscler"},{"key":"R13-20260220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R14-20260220","doi-asserted-by":"crossref","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"R15-20260220","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials.","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R16-20260220","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association.","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"R17-20260220","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1001\/jama.288.24.3137","article-title":"Recent trends in disability and functioning among older adults in the United States: a systematic review.","volume":"288","author":"Freedman","year":"2002","journal-title":"JAMA"},{"key":"R18-20260220","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jech.2004.026302","article-title":"Physical functioning in elderly Europeans: 10 Year changes in the north and south: the HALE project.","volume":"59","author":"\u00c4ij\u00e4nsepp\u00e4","year":"2005","journal-title":"J Epidemiol Community Health (1978)"},{"key":"R19-20260220","doi-asserted-by":"crossref","first-page":"18374","DOI":"10.1073\/pnas.0608483103","article-title":"Change in chronic disability from 1982 to 2004\/2005 as measured by long-term changes in function and health in the U.S. elderly population.","volume":"103","author":"Manton","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20260220","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2105\/AJPH.2007.128132","article-title":"Temporal trends in self-reported functional limitations and physical disability among the community-dwelling elderly population: the Framingham Heart Study.","volume":"98","author":"Murabito","year":"2008","journal-title":"Am J Public Health"},{"key":"R21-20260220","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199701303360520","article-title":"Book Review Ischemic Heart Disease: a rational basis for clinical practise and clinical research By Attilio Maseri. 713 pp., illustrated. New York, Churchill Livingstone, 1996. $115. 0-443-07910-2.","volume":"336","author":"Beller","year":"1997","journal-title":"N Engl J Med"},{"key":"R22-20260220","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","article-title":"Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial.","volume":"103","author":"Bech","year":"2001","journal-title":"Circulation"},{"key":"R23-20260220","doi-asserted-by":"crossref","first-page":"114E","DOI":"10.1016\/0002-9149(89)90242-7","article-title":"Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes.","volume":"63","author":"Falk","year":"1989","journal-title":"Am J Cardiol"},{"key":"R24-20260220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0735-1097(96)00203-3","article-title":"Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris.","volume":"28","author":"Chen","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R25-20260220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199907083410202","article-title":"Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R26-20260220","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.119.006363","article-title":"Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: a meta-analysis of randomized controlled trials.","volume":"13","author":"Chacko","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R27-20260220","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.104.521864","article-title":"Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.","volume":"111","author":"Katritsis","year":"2005","journal-title":"Circulation"},{"key":"R28-20260220","first-page":"472","article-title":"A meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with medical therapy in stable angina pectoris.","volume":"29","author":"Thomas","year":"2013","journal-title":"Can J Cardiol"},{"key":"R29-20260220","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","article-title":"Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials.","volume":"5","author":"Pursnani","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R30-20260220","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2008.05.051","article-title":"A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.","volume":"52","author":"Sch\u00f6mig","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R31-20260220","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"key":"R32-20260220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/heartjnl-2019-316075","article-title":"Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.","volume":"106","author":"Hennigan","year":"2020","journal-title":"Heart"},{"key":"R33-20260220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1915925","article-title":"Management of coronary disease in patients with advanced kidney disease.","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"R34-20260220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease.","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"key":"R35-20260220","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"R36-20260220","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa2310610","article-title":"A placebo-controlled trial of percutaneous coronary intervention for stable angina.","volume":"389","author":"Rajkumar","year":"2023","journal-title":"N Engl J Med"},{"key":"R37-20260220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3349\/ymj.2016.57.2.382","article-title":"Percutaneous coronary intervention is more beneficial than optimal medical therapy in elderly patients with angina pectoris.","volume":"57","author":"Won","year":"2016","journal-title":"Yonsei Med J"},{"key":"R38-20260220","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1253\/circj.CJ-17-0122","article-title":"Prevalence of thin-cap fibroatheroma in relation to the severity of anatomical and physiological stenosis.","volume":"81","author":"Usui","year":"2017","journal-title":"Circ J"},{"key":"R39-20260220","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jcmg.2019.06.013","article-title":"Adverse plaque characteristics relate more strongly with hyperemic fractional flow reserve and instantaneous wave-free ratio than with resting instantaneous wave-free ratio.","volume":"13","author":"Driessen","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"R40-20260220","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2017.10.011","article-title":"Correlation between frequency-domain optical coherence tomography and fractional flow reserve in angiographically-intermediate coronary lesions.","volume":"253","author":"Burzotta","year":"2018","journal-title":"Int J Cardiol"},{"key":"R41-20260220","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2018:8:2","article-title":"The newest generation of drug-eluting stents and beyond.","volume":"13","author":"Lee","year":"2018","journal-title":"Eur Cardiol"},{"key":"R42-20260220","first-page":"629","article-title":"Transradial versus transfemoral approach for coronary angiography and intervention in patients above 75 years of age.","volume":"72","author":"Achenbach","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"R43-20260220","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.amjcard.2004.07.089","article-title":"Comparison of transradial and transfemoral approaches for coronary angiography and angioplasty in octogenarians (the OCTOPLUS study).","volume":"94","author":"Louvard","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000406","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:00:26Z","timestamp":1771599626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/HPC.0000000000000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/hpc.0000000000000406","relation":{},"ISSN":["1535-2811"],"issn-type":[{"value":"1535-2811","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}